Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Clinical trial NCT01483950 · COMPLETED

Trial details

NCT number: NCT01483950
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Hypercholesterolaemia

Start date: 2012-04-01
Primary completion: 2013-01-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.